@article {Aspler:2008:1027-3719:928,
title = "Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia",
journal = "The International Journal of Tuberculosis and Lung Disease",
parent_itemid = "infobike://iuatld/ijtld",
publishercode ="iuatld",
year = "2008",
volume = "12",
number = "8",
publication date ="2008-08-01T00:00:00",
pages = "928-935",
itemtype = "ARTICLE",
issn = "1027-3719",
eissn = "1815-7920",
url = "https://www.ingentaconnect.com/content/iuatld/ijtld/2008/00000012/00000008/art00010",
keyword = "Zambia, tuberculosis, patient costs, economics",
author = "Aspler, A. and Menzies, D. and Oxlade, O. and Banda, J. and Mwenge, L. and Godfrey-Faussett, P. and Ayles, H.",
abstract = "SETTING: Urban primary health centres in Lusaka, Zambia.OBJECTIVES: 1) To estimate patient costs for tuberculosis (TB) diagnosis and treatment and 2) to identify determinants of patient costs.METHODS: A cross-sectional survey of 103 adult TB patients who had been on treatment for 13 months was conducted using a standardised questionnaire. Direct and indirect costs were estimated, converted into US$ and categorised into two time periods: pre-diagnosis/care-seeking and post-diagnosis/treatment. Determinants of patient costs were analysed using multiple linear regression.RESULTS: The median total patient costs for diagnosis and 2 months of treatment was $24.78 (interquartile range 13.5640.30) per patientequivalent to 47.8% of patients' median monthly income. Sex, patient delays in seeking care and method of treatment supervision were significant predictors of total patient costs. The total direct costs as a proportion of income were higher for women than men (P P CONCLUSION: Clinic-based treatment supervision posed a significant economic burden on patients. The creation or strengthening of community-based treatment supervision programmes would have the greatest potential impact on reducing patients' TB-related costs.",
}